Search research articles

Search research articles

Related Experiment Videos

Solid tumours--chemoprevention with retinoids

¹Roche International Clinical Research Centre, Lingolsheim, France.

|January 1, 1994

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Risk factors for new-onset diabetes mellitus following acute pancreatitis: a prospective study.

European review for medical and pharmacological sciences·2022

Same author

Leptin involvement in the survival of pancreatic adenocarcinoma patients with obesity and diabetes.

European review for medical and pharmacological sciences·2022

Same author

The mechanics of mitotic chromosomes.

Quarterly reviews of biophysics·2021

Same author

Solid tumours--chemoprevention with retinoids.

Leukemia·1994

Same author

EVA treatment for recurrent or unresponsive Hodgkin's disease.

Cancer chemotherapy and pharmacology·1986

Same author

[Incidence of B. cereus in raw milk and pasteurized milk].

Microbiologia, parazitologia, epidemiologia·1966

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Retinoids show promise in preventing new cancers, particularly in head and neck and breast cancer patients. Further research is needed to overcome challenges in clinical trial design and patient selection for effective retinoid chemoprevention.

Area of Science:

Oncology
Pharmacology

Background:

Solid tumor treatment is shifting towards early-stage intervention.
Retinoids are a promising drug class for cancer chemoprevention.
Different retinoids exhibit varying antitumor activities and synergistic potential with cytokines.

Framework:

Understanding retinoid receptor roles can optimize drug design for better therapeutic indices.
13-cis retinoic acid shows efficacy in preventing second primary head and neck cancers.
Fenretimide is under investigation for preventing second primary breast cancers.

Implementation:

Clinical development of retinoids faces challenges in study design and preclinical model relevance.
Optimal patient selection, dosing, scheduling, and treatment duration require further definition.

Related Experiment Videos

Biological surrogate markers can accelerate clinical trial development for chemopreventive agents.

Implications:

Ongoing studies, especially in tobacco-related diseases, will clarify retinoids' role in cancer prevention.
Large, well-organized clinical studies are crucial for advancing retinoid chemoprevention.
Retinoids offer a potential strategy for reducing cancer recurrence and new primary tumor development.